3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms
1
Meningioma
1
Malignant Female Reproductive System Neoplasm
1
Hemangiosarcoma
1
Fallopian Tube Neoplasms
1
Ependymoma
1
Endometrial Neoplasms
1
Disease Progression
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Letrozole
4
Fulvestrant
4
trastuzumab deruxtecan
2
toripalimab
2
elacestrant
2
Injections
2
Anastrozole
2
AZD9833
2
ribociclib
1
palbociclib
1
exemestane
1
disitamab vedotin
1
abemaciclib
1
Selective Estrogen Receptor Modulators
1
Ritonavir
1
RAD1901
1
Paclitaxel
1
Lead
1
Itraconazole
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Everolimus
1
Alpelisib
1
AZD5305
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Breast Cancer
×
neratinib
×
90 days
×
Clear all
No trials found.